Skip to main content
SpringerLink
Log in

Carcinoid Tumors

  • Chapter
Endoscopic Oncology

Abstract

Carcinoid tumors are of neuroendocrine origin, and can produce bioactive peptides or amines that rarely produce clinical symptoms. These tumors are slow growing, and infrequently produce the so-called carcinoid syndrome, cardinal features of which are flushing and diarrhea. About two-thirds of carcinoid tumors are found in the gastrointestinal (GI) tract, one-fourth in the bronchopulmonary tree, and the remainder in the urogenital tract. Presentation, behavior, and malignant potential of carcinoid tumors are determined by the site at which they originate. Resection of the tumor is the only curative option, but advances in the understanding of the biology of carcinoids have produced therapies that can effectively treat symptoms caused by these tumors.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Caplin ME, et al. Carcinoid tumour. Lancet 1998; 352(9130): 799–805.

    PubMed  CAS  Google Scholar 

  2. Lubarsch O. Ueber den primaren Krebs des Ileum, nebst Bemerkungen uber das gleichzeitige Vorkommen von Krebs und Tuberkolose. Virchows Arch 1888; 111:280–317.

    Google Scholar 

  3. Oberndorfer S. Karzinoide tumoren des dunndarms. Frank Z Pathol 1907; 1:425–429.

    Google Scholar 

  4. Masson P. Carcinoids (argentaffin-cell tumors) and nerve hyperplasia of appendicular mucosa. Am J Pathol 1928; 4:181–212.

    Google Scholar 

  5. Lembech F. 5-hydroxytryptamine in carcinoid tumor. Nature 1953; 172:p. 910–911.

    Google Scholar 

  6. Page I, Corcoran A, Vollenfrend S. Argentaffinoma as an endocrine tumor. Lancet 1955; 1:198,199.

    Google Scholar 

  7. Todd TR, et al. Bronchial carcinoid tumors: twenty years’ experience. J Thor Cardiovasc Surg 1980; 79(4):532–536.

    CAS  Google Scholar 

  8. Neary PC, et al. Carcinoid disease: review of the literature. Dis Colon Rectum 1997; 40(3):349–362.

    PubMed  CAS  Google Scholar 

  9. Moertel C, et al. Life history of the carcinoid tumor of the small intestine. Cancer 1961; 14:901–912.

    PubMed  CAS  Google Scholar 

  10. Eller R, Frazee R, Roberts J. Gastrointestinal carcinoid tumors. Am Surgeon 1991; 57:434–437.

    PubMed  CAS  Google Scholar 

  11. Berge T, Linell F. Carcinoid tumours. Frequency in a defined population during a 12-year period. Acta Pathol et Microbiol Scand— Section A Pathol 1976; 84(4):322–330.

    CAS  Google Scholar 

  12. Modlin IM, Lye KD, Kidd M. A 5-decade analysis of 13,715 carcinoid tumors. Cancer 2003; 97(4):934–959.

    PubMed  Google Scholar 

  13. Limper AH, et al. The Cushing syndrome induced by bronchial carcinoid tumors. Ann Int Med 1992; 117(3):209–214.

    PubMed  CAS  Google Scholar 

  14. Wajchenberg BL, et al. Ectopic ACTH syndrome. (erratum appears in J Steroid Biochem Mol Biol 1995 Sep;54(5-6):287). J Steroid Biochem Mol Biol 1995; 53(1-6):139–151.

    PubMed  CAS  Google Scholar 

  15. Modlin IM, Sandor A. An analysis of 8305 cases of carcinoid tumors. Cancer 1997; 79(4):813–829.

    PubMed  CAS  Google Scholar 

  16. Woods HF Bax ND, Ainsworth I. Abdominal carcinoid tumours in Sheffield. Digestion 1990; 45(Suppl 1):17–22.

    PubMed  Google Scholar 

  17. Newton JN, et al. The epidemiology of carcinoid tumours in England and Scotland. Br J Cancer 1994; 70(5):939–942.

    PubMed  CAS  Google Scholar 

  18. Lu Cortez L, et al. (Carcinoid tumor. An analysis of 131 cases). Revista Clinica Espanola 1994; 194(4):291–293.

    Google Scholar 

  19. Soga J. Carcinoids of the rectum an evaluation of 1271 reported casesSurgery Today 1997; 27(2):112–119.

    PubMed  CAS  Google Scholar 

  20. Waldum HL, Haugen OA, Brenna E. Do neuroendocrine cells particularly the D-cellplay a role in the development of gastric stump cancer Cancer Detection & Prevention 1994; 18(6):431–46.

    CAS  Google Scholar 

  21. Kulke MH, Mayer RJ. Carcinoid tumors. N Eng J of Med 1999; 340(11):858–868.

    CAS  Google Scholar 

  22. Anthony T, Kim L. Gastrointestinal Carcinoid Tumors and the Carcinoid Syndromein Sleisenger & Fordtran’s Gastrointestinal and Liver Disease Feldman M Friedman LS, Sleisenger MH. eds. Saunders: Philadelphia; 2002; 2151–2168.

    Google Scholar 

  23. Vyberg M, et al. Immunohistochemical identification of neuron-specific enolasesynaptophysinchromogranin and endocrine granule constituent in neuroendocrine tumours. Acta Histochemica— Supplement B 1990; 38:179–181.

    CAS  Google Scholar 

  24. Capella C, et al. Revised classification of neuroendocrine tumors of the lungpancreas and gut. Digestion. 1994; 55(Suppl 3):11–23.

    PubMed  Google Scholar 

  25. Williams E, Sanders M. The classification of carcinoid tumors. Lancet 1963; 1:238,239.

    Google Scholar 

  26. Soga J, Tazawa K. Pathologic analysis of carcinoids. Histologic reevaluation of 62 cases. Cancer 1971; 28(4):990–998.

    PubMed  CAS  Google Scholar 

  27. Yang K, et al. The neuroendocrine products of intestinal carcinoids. An immunoperoxidase study of 35 carcinoid tumors stained for serotonin and eight polypeptide hormones. Cancer 1983; 51(10): 1918–1926.

    PubMed  CAS  Google Scholar 

  28. Lindberg GM, et al. Atypical carcinoid of the esophagus: a case report and review of the literature. Cancer 1997; 79(8): 1476–1481.

    PubMed  CAS  Google Scholar 

  29. Modlin IM, Lye KD, Kidd M. A 50-year analysis of 562 gastric carcinoids: small tumor or larger problem Am J Gastroenterol 2004; 99(1):23–32.

    PubMed  Google Scholar 

  30. Rindi G, et al. Gastric carcinoids and neuroendocrine carcinomas, pathogenesis, pathology and behavior. World J Surg 1996; 20(2): 168–172.

    PubMed  CAS  Google Scholar 

  31. Havu N. Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion. Digestion 1986; 35(Suppl 1):42–55.

    PubMed  Google Scholar 

  32. Klinkenberg-Knol EC, et al. Long-term treatment with omeprazole for refractory reflux esophagitisefficacy and safety (see comment) Ann Intern Med 1994; 121(3):161–167.

    PubMed  CAS  Google Scholar 

  33. Bordi C. Endocrine tumours of the stomach. Pathol Res Pract 1995; 191(4):373–380.

    PubMed  CAS  Google Scholar 

  34. Modlin IM, Lye KD, Kidd M. Carcinoid tumors of the stomach. Surg Oncol 2003; 12(2):153–172.

    PubMed  Google Scholar 

  35. Rindi G, et al. Three subtypes of gastric argyrophil carcinoid and the gastric neuroendocrine carcinomaa clinicopathologic study (see comment) Gastroenterology 1993; 104(4):994–1006.

    PubMed  CAS  Google Scholar 

  36. Gough DB, et al. Diverse clinical and pathologic features of gastric carcinoid and the relevance of hypergastrinemia. World J Surg 1994; 18(4):473–479 discussion 479, 480.

    PubMed  CAS  Google Scholar 

  37. Moses RE, et al. The syndrome of type A chronic atrophic gastritis pernicious anemia and multiple gastric carcinoids. J Clin Gastroenterol 1986; 8(1):61–65.

    PubMed  Google Scholar 

  38. Hunt GC, Smith PP, Faigel DO. Yield of tissue sampling for submucosal lesions evaluated by EUS. Gastrointestinal Endosc 2003; 57(1):68–72.

    Google Scholar 

  39. Gilligan CJ, et al., Gastric carcinoid tumors: the biology and therapy of an enigmatic and controversial lesion. Am J Gastroenterol 1995; 90(3):338–352.

    PubMed  CAS  Google Scholar 

  40. Debelenko LV, et al. The multiple endocrine neoplasia type I gene locus is involved in the pathogenesis of type n gastric carcinoids. Gastroenterology 1997; 113(3):773–781.

    PubMed  CAS  Google Scholar 

  41. Maurer CA, et al. Carcinoid of the pancreas: clinical characteristics and morphological features. Eur J Cancer 1996; 32A(7):1109–1116.

    PubMed  CAS  Google Scholar 

  42. Gudjonsson B., Carcinoma of the pancreas: critical analysis of costs, results of resectionsand the need for standardized reporting (see comment) J Am College Surgeons 1995; 181(6):483–503.

    CAS  Google Scholar 

  43. Knox CD, et al. Long-term survival after resection for primary hepatic carcinoid tumor(see comment) Ann Surgical Oncol 2003; 10(10):1171–1175.

    Google Scholar 

  44. Podnos YD, et al. Carcinoid tumors of the common bile duct: report of two cases. Surg Today 2003; 33(7):553–535.

    PubMed  Google Scholar 

  45. Makhlouf HR, Burke AP, Sobin LH. Carcinoid tumors of the ampulla of Vater: a comparison with duodenal carcinoid tumors. Cancer 1999; 85(6):1241–1249.

    PubMed  CAS  Google Scholar 

  46. Burke AP, et al. Carcinoid tumors of the duodenum. A clinicopathologic study of 99 cases. Arch Pathol Lab Med 1990; 114(7):700–704.

    PubMed  CAS  Google Scholar 

  47. Klein A, Clemens J, Cameron J. Periampullary neoplasms in von Recklinghausen’s disease. Surgery 1989; 106(5):815–819.

    PubMed  CAS  Google Scholar 

  48. Yoshikane H, et al. Endoscopic resection of small duodenal carcinoid tumors with strip biopsy technique. Gastrointestinal Endoscopy 1998; 47(6):466–470.

    PubMed  CAS  Google Scholar 

  49. Yamamoto C, et al. Carcinoid tumors of the duodenum: report of three cases treated by endoscopic resection. Endoscopy 1997; 29(3):218–221.

    PubMed  CAS  Google Scholar 

  50. Nishimori I, et al. Endosonography-guided endoscopic resection of duodenal carcinoid tumor. Endoscopy. 1997; 29(3):214–217.

    PubMed  CAS  Google Scholar 

  51. Barclay TH, Schapira DV. Malignant tumors of the small intestine. Cancer 1983; 51(5):878–881.

    PubMed  CAS  Google Scholar 

  52. North JH, Pack MS. Malignant tumors of the small intestine: a review of 144 cases. Am Surgeon 2000; 66(1):46–51.

    PubMed  CAS  Google Scholar 

  53. Eckhauser FE, et al. Mesenteric angiopathy, intestinal gangrene, and midgut carcinoids. Surgery 1981; 90(4):720–728.

    PubMed  CAS  Google Scholar 

  54. Burke AP, et al. Carcinoids of the jejunum and ileum: an immuno-histochemical and clinicopathologic study of 167 cases. Cancer 1997;79(6):1086–1093.

    PubMed  CAS  Google Scholar 

  55. Loftus JP, van Heerden JA. Surgical management of gastrointestinal carcinoid tumors. Advances in Surg 1995; 28:317–336.

    CAS  Google Scholar 

  56. Wangberg B, et al. Survival of patients with disseminated midgut carcinoid tumors after aggressive tumor reduction. World J Surg 1996; 20(7):p. 892–899; discussion 899.

    PubMed  CAS  Google Scholar 

  57. Makridis C, et al. Progression of metastases and symptom improvement from laparotomy in midgut carcinoid tumors. World Surg. 1996; 20(7):900–906; discussion 907.

    CAS  Google Scholar 

  58. Anderson DJ. Carcinoid tumor in Meckel’s diverticulum: laparo-scopic treatment and review of the literature. J Am Osteopathic Assoc 2000; 100(7):432–434.

    CAS  Google Scholar 

  59. Moyana TN. Carcinoid tumors arising from Meckel’s diverticulum. A clinical, morphologic, and immunohistochemical study. Am J Clin Pathol. 1989; 91(1):52–56.

    PubMed  CAS  Google Scholar 

  60. Goede AC, Caplin ME, Winslet MC. Carcinoid tumour of the appendix. Br J Surg. 2003; 90(11):1317–1322.

    PubMed  CAS  Google Scholar 

  61. McCusker ME, et al. Primary malignant neoplasms of the appendix: a population-based study from the surveillance, epidemiology and end-results program, 1973-1998. Cancer 2002; 94(12):3307–3312.

    PubMed  Google Scholar 

  62. Moertel CG, et al. Carcinoid tumor of the appendix: treatment and prognosis. N Engl J Med 1987; 317(27):1699–1701.

    PubMed  CAS  Google Scholar 

  63. Rosenberg JM. Welch JP. Carcinoid tumors of the colon. A study of 72 patients. Am J Surg 1985; 149(6):775–779.

    PubMed  CAS  Google Scholar 

  64. Berardi RS. Carcinoid tumors of the colon (exclusive of the rectum): review of the literature. Dis Colon Rectum 1972;15(5):383–391.

    PubMed  CAS  Google Scholar 

  65. Saha S, et al. Carcinoid tumors of the gastrointestinal tract: a 44-year experience. Southern Med J. 1989; 82(12):1501–1505.

    CAS  Google Scholar 

  66. Olney JR, et al. Carcinoid tumors of the gastrointestinal tract. AmSurgeon 1985; 51(1):37–41.

    CAS  Google Scholar 

  67. Ballantyne GH, et al. Incidence and mortality of carcinoids of the colon. Data from the Connecticut Tumor Registry. Cancer 1992; 69(10):2400–2405.

    PubMed  CAS  Google Scholar 

  68. Thomas RM, Sobin LH. Gastrointestinal cancer. Cancer 1995; 75(1 Supp1):154–170.

    PubMed  CAS  Google Scholar 

  69. Spread C, et al. Colon carcinoid tumors. A population-based study. Dis Colon Rectum 1994; 37(5):482–491.

    PubMed  CAS  Google Scholar 

  70. Schindl M, et al. Stage-dependent therapy of rectal carcinoid tumors. World J Surg. 1998; 22(6):628–633; discussion 634.

    PubMed  CAS  Google Scholar 

  71. Jetmore AB, et al. Rectal carcinoids: the most frequent carcinoid tumor. Dis Colon & Rectum 1992; 35(8): 717–725.

    CAS  Google Scholar 

  72. Mani S, et al. Carcinoids of the rectum. J Am College Surgeons. 1994; 179(2):231–248.

    CAS  Google Scholar 

  73. Naunheim KS, et al. Rectal carcinoid tumors—treatment and prognosis. Surgery. 1983; 94(4):670–676.

    PubMed  CAS  Google Scholar 

  74. Yoshida M, et al. Endoscopic assessment of invasion of colo-rectal tumors with a new high-frequency ultrasound probe. Gastrointestinal Endoscopy. 1995; 41(6):587–592.

    PubMed  CAS  Google Scholar 

  75. Sauven P, et al. Anorectal carcinoid tumors. Is aggressive surgery warranted? (see comment). Ann Surg 1990; 211(1):67–71.

    PubMed  CAS  Google Scholar 

  76. Koura AN, et al. Carcinoid tumors of the rectum:effect of size, histopathology, and surgical treatment on metastasis free survival. Cancer. 1997; 79(7):1294–1298.

    PubMed  CAS  Google Scholar 

  77. Mc Mullan DM, Wood DE. Pulmonary carcinoid tumors. Sem Thor Cardiovasc Surg 2003; 15(3):289–300.

    Google Scholar 

  78. Carroll DG, et al. Resolution of acromegaly after removal of a bronchial carcinoid shown to secrete growth hormone releasing factor. Austr N Zeal J Med 1987; 17(1):63–67.

    CAS  Google Scholar 

  79. Chughtai TS, et al. Bronchial carcinoid—twenty years’ experience defines a selective surgical approach. Surgery 1997; 122(4):801–808.

    PubMed  CAS  Google Scholar 

  80. Marshall JB, Bodnarchuk G. Carcinoid tumors of the gut. Our experience over three decades and review of the lite J Clin Gastroenterol. 1993; 16(2):123–129.

    PubMed  CAS  Google Scholar 

  81. Rosenbaum FD, Claudon D. Essential telangiectasia, pulmonic and tricuspid stenosis, and neoplastic liver disease: A possible new clinical syndrome. J Lab Clin Med 1953; 42:941.

    Google Scholar 

  82. Thorson A, Bjork G, Bjorkman G. Malignant carcinoid of the small intestine with metastasis to the liver, valvular disease of the right heart (pulmonary stenosis and tricuspid regurgitation without septal defect), peripheral vasomotor symptoms, bronchoconstriction and an unusual type of cyanosis. Am Heart J 1954; 47:794.

    Google Scholar 

  83. Creutzfeldt W. Historical background and natural history of carcinoids. Digestion 1994; 55(Suppl 3):3–10.

    PubMed  Google Scholar 

  84. Kloppel G, Heitz PU. Classification of normal and neoplastic neuroendocrine cells. Ann NY Acad Sci 1994; 733:19–23.

    PubMed  CAS  Google Scholar 

  85. Wilander E. Diagnostic pathology of gastrointestinal and pancreatic neuroendocrine tumours. Acta Oncologica. 1989; 28(3):363–369.

    PubMed  CAS  Google Scholar 

  86. Feldman JM. Carcinoid tumors and the carcinoid syndrome. Curr Problems Surg 1989; 26(12):835–885.

    CAS  Google Scholar 

  87. Creutzfeldt W. Carcinoid tumors: development of our knowledge. World J Surg. 1996; 20(2):126–131.

    PubMed  CAS  Google Scholar 

  88. Bax ND, et al. Clinical manifestations of carcinoid disease. World J Surg 1996; 20(2):142–146.

    PubMed  CAS  Google Scholar 

  89. Vaughan DJ, Brunner MD, Anesthesia for patients with carcinoid syndrome. Inter Anesthesiol Clinics 1997; 35(4):129–142.

    CAS  Google Scholar 

  90. Rubin J, et al. Octreotide acetate long-acting formulation versus open-label subcutaneous octreotide acetate in malignant carcinoid syndrome. J Clinical Oncol 1999; 17(2):600–606.

    CAS  Google Scholar 

  91. Creutzfeldt W, Stockmann F. Carcinoids and carcinoid syndrome. Am J Med 1987; 82(5B):4–16.

    PubMed  CAS  Google Scholar 

  92. Richter G, et al. Serotonin release into blood after food and pentagastrin. Studies in healthy subjects and in patients with metastatic carcinoid tumors. Gastroenterol 1986; 91(3):612–618.

    CAS  Google Scholar 

  93. Lucas KJ, Feldman JM. Flushing in the carcinoid syndrome and plasma kallikrein. Cancer 1986; 58(10):2290–2293.

    PubMed  CAS  Google Scholar 

  94. Saslow SB, et al. Octreotide inhibition of flushing and colonic motor dysfunction in carcinoid syndrome. Am J Gastroenterol 1997; 92(12):2250–2256.

    PubMed  CAS  Google Scholar 

  95. von der Ohe MR, et al. Motor dysfunction of the small bowel and colon in patients with the carcinoid syndrome and diarrhea. (erratum appears in N Engl J Med 1993 Nov 18;329(21):1592). New Engl J Med. 1993; 329(15):1073–1078.

    PubMed  Google Scholar 

  96. Ahlman H, et al. The pentagastrin test in the diagnosis of the carcinoid syndrome. J Cardiovascular Pharmacol. 1985; 7(Suppl 7): S86–S88.

    Google Scholar 

  97. Moertel CG. Karnofsky memorial lecture. An odyssey in the land of small tumors. J Clin Oncol 1987; 5(10):1502–1522.

    PubMed  CAS  Google Scholar 

  98. Siu LL, Chapman W, Moore MJ. Use of the somatostatin analogue octreotide acetate in the treatment of encephalopathy associated with carcinoid tumor. Case report. Am J Clinical Oncol 1997; 20(6):558–561.

    CAS  Google Scholar 

  99. Pellikka PA, et al. Carcinoid heart disease. Clinical and echocardiographic spectrum in 74 patients. Circulation 1993; 87(4):1188–1196.

    PubMed  CAS  Google Scholar 

  100. Lundin L, et al. Transoesophageal echocardiography improves the diagnostic value of cardiac ultrasound in patients with carcinoid heart disease. Br Heart J 1990; 64(3):190–194.

    PubMed  CAS  Google Scholar 

  101. Howard RJ, et al. Carcinoid heart disease: diagnosis by two-dimensional echocardiography. Circulation 1982; 66(5):1059–1065.

    PubMed  CAS  Google Scholar 

  102. Lundin L, et al. Carcinoid heart disease: relationship of circulating vasoactive substances to ultrasound-detectable cardiac abnormalities. Circulation 1988; 77(2):264–269.

    PubMed  CAS  Google Scholar 

  103. Moyssakis IE, et al. Incidence and evolution of carcinoid syndromein the heart. J Heart Valve Dis 1997; 6(6):625–630.

    PubMed  CAS  Google Scholar 

  104. Roberts LJ, 2nd, Marney SR, Jr, Oates JA. Blockade of the flush associated with metastatic gastric carcinoid by combined histamine H1 and H2 receptor antagonists. Evidence for an important role of H2 receptors in human vasculature. N Engl J Med 1979; 300(5):236–238.

    PubMed  Google Scholar 

  105. Basson MD, et al. Biology and management of the midgut carcinoid. Am J Surg 1993; 165(2):288–297.

    PubMed  CAS  Google Scholar 

  106. Veall GR, et al. Review of the anaesthetic management of 21 patients undergoing laparotomy for carcinoid syndrome. (see comment) Br J Anaesthesia 1994; 72(3):335–341.

    CAS  Google Scholar 

  107. Tormey WP, Fitz Gerald RJ. The clinical and laboratory correlates of an increased urinary 5-hydroxyindoleacetic acid. Postgraduate Mel Jl. 1995; 71(839):542–545.

    CAS  Google Scholar 

  108. Schnirer II, Yao JC, Ajani JA. Carcinoid—a comprehensive review. Acta Oncologica. 2003; 42(7):672–692.

    PubMed  Google Scholar 

  109. Krenning EP, et al. Radiotherapy with a radiolabeled somatostatin analogue (111In-DTPA-D-Phe1)-octreotide. A case history. Ann NY Acad Sci 1994; 733:496–506.

    PubMed  CAS  Google Scholar 

  110. Westlin JE, et al. Somatostatin rec eptor scintigraphy of carcinoidtumours using the (111In-DTPA-D-Phe1)-octreotide. Acta Oncologica. 1993; 32(7-8):783–786.

    PubMed  CAS  Google Scholar 

  111. Shi W, et al. Localization of neuroendocrine tumours with (11 1In)DTPA-octreotide scintigraphy (Octreoscan): a comparative study with CT and MR imaging. Qjm 1998; 91(4): 295–301.

    PubMed  CAS  Google Scholar 

  112. Anthony LB, et al. Somatostatin receptor imaging: predictive and prognostic considerations. Digestion 1996; 57(Suppl 1):50–53.

    PubMed  CAS  Google Scholar 

  113. Krenning EP, et al. Somatostatin receptor: scintigraphy and radionuclide therapy. Digestion. 1996; 57(Suppl 1):57–61.

    PubMed  CAS  Google Scholar 

  114. Kwekkeboom DJ, Krenning EP. Somatostatin receptor scintigraphy in patients with carcinoid tumors. World J Surg 1996; 20(2): 157–161.

    PubMed  CAS  Google Scholar 

  115. Ahlman H, et al. Somatostatin receptors on neuroendocrine tumors—a way to intraoperative diagnosis and localization. Yale J BioMed 1994; 67(3-4):215–221.

    CAS  Google Scholar 

  116. Lobrano MB, et al. Metastatic carcinoid tumor imaged with CT and a radiolabeled somatostatin analog: a case report. Am J Gastroenterol 1997; 92(3): 513–515.

    PubMed  CAS  Google Scholar 

  117. Eriksson B, et al. Positron emission tomography (PET) in neuroendocrine gastrointestinal tumors. Acta Oncologica. 1993;32(2): 189–196.

    PubMed  CAS  Google Scholar 

  118. Eriksson B, et al. The role of PET in localization of neuroendocrine and adrenocortical tumors. Ann NY Acad Sci 2002; 970:159–169.

    PubMed  CAS  Google Scholar 

  119. Lamberts SW, et al. Long-term treatment of acromegaly with the somatostatin analogue SMS 201-995. New Engl J Med. 1985; 313(25):1576–1580.

    PubMed  CAS  Google Scholar 

  120. Schally AV. Oncological applications of somatostatin analogues, (erratum appears in Cancer Res 1989 Mar 15;49(6):1618). Can Res 1988; 48(24 Pt 1):6977–6985.

    CAS  Google Scholar 

  121. Kvols LK, et al. Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue. New Engl J Med 1986; 315(11):663–666.

    PubMed  CAS  Google Scholar 

  122. Oberg K Norheim I. Theodorsson E. Treatment of malignant midgut carcinoid tumours with a long-acting somatostatin analogueoctreotide. Acta Oncologica. 1991; 30(4):503–507.

    PubMed  CAS  Google Scholar 

  123. Tomassetti P, Migliori M, Gullo L. Slow-release lanreotide treatment in endocrine gastrointestinal tumors. Am J Gastroenterol 1998; 93(9):1468–1471.

    PubMed  CAS  Google Scholar 

  124. Saltz L, et al. Octreotide as an antineoplastic agent in the treatment of functional and nonfunctional neuroendocrine tumors. Cancer. 1993; 72(1):244–248.

    PubMed  CAS  Google Scholar 

  125. Janson ET, et al. Treatment with alpha-interferon versus alphainterferon in combination with streptozocin and doxorubicin in patients with malignant carcinoid tumors: a randomized trial. Ann Oncol 1992; 3(8):635–638.

    PubMed  CAS  Google Scholar 

  126. Janson ET, Oberg K. Long-term management of the carcinoid syndrome. Treatment with octreotide alone and in combination with alpha-interferon. Acta Oncologica. 1993; 32(2):225–229.

    PubMed  CAS  Google Scholar 

  127. Arnold R, et al. Somatostatin analogue octreotide and inhibition oftumour growth in metastatic endocrine gastroenteropancreatic tumours. Gut. 1996; 38(3):430–438.

    PubMed  CAS  Google Scholar 

  128. Oberg K, Funa K, Alm G. Effects of leukocyte interferon on clinical symptoms and hormone levels in patients with mid-gut carcinoid tumors and carcinoid syndrome. New Engl J Med 1983; 309(3):129–133.

    PubMed  CAS  Google Scholar 

  129. Creutzfeldt W, et al. Treatment of gastrointestinal endocrine tumours with interferon-alpha and octreotide. Acta Oncologica 1991; 30(4):529–535.

    PubMed  CAS  Google Scholar 

  130. Hanssen LE, et al. Treatment of malignant metastatic midgut carcinoid tumours with recombinant human alpha2b interferon with or without prior hepatic artery embolization. Scandinavian J. Gastroenterol. 1989; 24(7):787–795.

    CAS  Google Scholar 

  131. Moertel CGJ, Kvols LK. Therapy of metastatic carcinoid tumor and the malignant carcinoid syndrome with recombinant leukocyte A interferon. J Clin Oncol 1989; 7(7):865–868.

    PubMed  CAS  Google Scholar 

  132. Oberg K, et al. Treatment of malignant carcinoid tumors with recombinant interferon alfa-2b: development of neutralizing interferon antibodies and possible loss of antitumor activity. J National Cancer Institute 1989; 81(7):531–535.

    CAS  Google Scholar 

  133. Oberg K, Eriksson B. The role of interferons in the management of carcinoid tumours. Bri J Haematol 1991; 79(Suppl 1):74–77.

    Google Scholar 

  134. Schober C, et al. Antitumour effect and symptomatic control with interferon alpha 2b in patients with endocrine active tumours. Euro JCancer., 1992; 28A(10):1664–1666.

    CAS  Google Scholar 

  135. Joensuu H, Kumpulainen E, Grohn P. Treatment of metastatic carcinoid tumour with recombinant interferon alfa. Eur J Cancer 1992; 28A(10):1650–1653.

    PubMed  CAS  Google Scholar 

  136. Bajetta E, et al. Treatment of metastatic carcinoids and other neuroendocrine tumors with recombinant interferon-alpha-2a. A study by the Italian Trials in Med Oncol Group. Cancer 1993;72(10):3099–3105.

    PubMed  CAS  Google Scholar 

  137. Di Bartolomeo M, et al. Treatment of carcinoid syndrome with recombinant interferon alpha-2a(erratum appears in Acta Oncol 1993;32(5):592). Acta Oncologica 1993; 32(2):235–238.

    PubMed  Google Scholar 

  138. Jacobsen MB, et al. Interferon-alpha 2b, with or without prior hepatic artery embolization: clinical response and survival in midgut carcinoid patients. The Norwegian carcinoid study. Scand J Gastroenterol 1995; 30(8):789–796.

    PubMed  CAS  Google Scholar 

  139. Frank M, et al. Combination therapy with octreotide and alpha-interferon: effect on tumor growth in metastatic endocrine gastroenteropancreatic tumors. Am J Gastroenterol 1999;94(5):1381–1387.

    PubMed  CAS  Google Scholar 

  140. Saltz L, et al. A phase n trial of alpha-interferon and 5-fluorouracil in patients with advanced carcinoid and islet cell tumors. Cancer 1994;74(3):958–961.

    PubMed  CAS  Google Scholar 

  141. Nobin A, Mansson B, Lunderquist A. Evaluation of temporary liver dearterialization and embolization in patients with metastatic carcinoid tumour. Acta Oncologica 1989; 28(3):419–424.

    PubMed  CAS  Google Scholar 

  142. Carrasco CH, et al. The carcinoid syndrome: palliation by hepatic artery embolization. AJR. Am J Roentgenol 1986;147(1):149–154.

    PubMed  CAS  Google Scholar 

  143. Eriksson BK, et al. Liver embolizations of patients with malignant neuroendocrine gastrointestinal tumors. Cancer 1998;83(11): 2293–2301.

    PubMed  CAS  Google Scholar 

  144. Ruszniewski P, et al. Hepatic arterial chemoembolization in patients with liver metastases of endocrine tumors. A prospective phase n study in 24 patients. Cancer 1993; 71(8):2624–2630.

    PubMed  CAS  Google Scholar 

  145. Therasse E, et al. Transcatheter chemoembolization of progressivecarcinoid liver metastasis. Radiology 1993; 189(2):541–547.

    PubMed  CAS  Google Scholar 

  146. Perry LJ, et al. Hepatic arterial chemoembolization for metastaticneuroendocrine tumors. Surgery 1994; 116(6):1111–1116; discussion 1116-1117.

    PubMed  CAS  Google Scholar 

  147. Drougas JG, et al. Hepatic artery chemoembolization for management of patients with advanced metastatic carcinoid tumors. Am J Surg 1998; 175(5):408–412.

    PubMed  CAS  Google Scholar 

  148. Diamandidou E, et al. Two-phase study of hepatic artery vascular occlusion with microencapsulated cisplatin in patients with liver metastases from neuroendocrine tumors. AJR. Am J Roentgenol 1998; 170(2):339–344.

    PubMed  CAS  Google Scholar 

  149. Kim YH, et al. Selective hepatic arterial chemoembolization for liver metastases in patients with carcinoid tumor or islet cell carcinoma. Cancer Investigation 1999; 17(7):474–478.

    PubMed  CAS  Google Scholar 

  150. Gates J, et al. Chemoembolization of hepatic neoplasms: safety, complications, and when to worry. Radiographics 1999;19(2):399–414.

    PubMed  CAS  Google Scholar 

  151. Schupak KD, Wallner KE. The role of radiation therapy in the treatment of locally unresectable or metastatic carcinoid tumors. Inter J Radiation Oncol Biol Physics 1991; 20(3):489–495.

    CAS  Google Scholar 

  152. Que FG, et al. Hepatic resection for metastatic neuroendocrine carcinomas. Am J Surg 1995; 169(1):36–42; discussion 42, 43.

    PubMed  CAS  Google Scholar 

  153. Inai M, et al. Endosonographic characterization of duodenal elevated lesions. Gastrointest Endosc 1996; 44(6):714–719.

    PubMed  CAS  Google Scholar 

  154. Chak A. EUS in submucosal tumors. Gastrointestinal Endoscopy 2002; 56(4 Suppl):S43–S48.

    PubMed  Google Scholar 

  155. Soetikno RM, et al. Endoscopic mucosal resection. Gastrointest Endosc 2003; 57(4):567–579.

    PubMed  Google Scholar 

  156. Inoue H, et al. Endoscopic mucosal resection with a cap-fitted panendoscope for esophagus, stomach, and colon mucosal lesions. Gastrointest Endosc 1993; 39(1):58–62.

    PubMed  CAS  Google Scholar 

  157. Suzuki Y, et al. Treatment of gastric tumors by endoscopic mucosal resection with a ligating device. Gastrointest Endosc 1999; 49(2): 192–199.

    PubMed  CAS  Google Scholar 

  158. Rau BK, Harikrishnan KM. Krishna S. Endoscopic laser ablation of duodenal carcinoids: a new treatment modality. J Clin Laser MedSurg 1995; 13(1):37–38.

    CAS  Google Scholar 

  159. Berkelhammer C, et al. “Band-snare” resection of small rectal carcinoid tumors. Gastrointestinal Endoscopy 1999; 50(4):582–585.

    PubMed  CAS  Google Scholar 

  160. Lachter J, Chemtob J. EUS may have limited impact on the endoscopic management of gastric carcinoids. Inter J Gastrointestinal Cancer 2002; 31(1-3):181–183.

    Google Scholar 

  161. Ichikawa J, et al. Endoscopic mucosal resection in the management of gastric carcinoid tumors. Endoscopy 2003; 35(3):203–206.

    PubMed  CAS  Google Scholar 

  162. Ono A, et al. Endoscopic submucosal resection of rectal carcinoid tumors with a ligation device. Gastrointest Endosc 2003; 57(4): 583–587.

    PubMed  Google Scholar 

  163. Maeda K, et al. Minimally invasive surgery for carcinoid tumors in the rectum. Biomed Pharmacotherapy 2002; 56(Suppl 1):222s–226s.

    Google Scholar 

  164. Higaki S, et al. Effectiveness of local endoscopic resection of rectal carcinoid tumors. Endoscopy 1997; 29(3):171–175.

    PubMed  CAS  Google Scholar 

  165. de Mascarenhas-Saraiva MN, da Silva Araujo Lopes LM. Small-bowel tumors diagnosed by wireless capsule endoscopy: report of five cases. Endoscopy 2003; 35(10):865–868.

    PubMed  Google Scholar 

  166. Voderholzer WA, et al. Diagnostic yield of wireless capsule enteroscopy in comparison with computed tomography enteroclysis. Endoscopy 2003; 35(12):1009–1014.

    PubMed  CAS  Google Scholar 

  167. Coates SW Jr, DeMarco DC. Metastatic carcinoid tumor discovered by capsule endoscopy and not detected by esophagogastro-duodenoscopy. Dig Dis Sci 2004; 49(4):639–641.

    PubMed  Google Scholar 

  168. Bresky G, et al. Endoscopic findings in a biennial follow-up program in patients with pernicious anemia. Hepatogastroenterology 1999; 50(54):2264–2266.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Division of Gastroenterology, University of California, San Diego, CA

    Willscott E. Naugler MD & Gordon C. Hunt MD

Authors
  1. Willscott E. Naugler MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Gordon C. Hunt MD
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Oregon Health and Science University, Portland, OR

    Douglas O. Faigel MD, FACG, FASGE (Associate Professor of Medicine, Director of Endoscopy) (Associate Professor of Medicine, Director of Endoscopy)

  2. Hospital of the University of Pennsylvania, Philadelphia, PA

    Michael L. Kochman MD, FACP, FASGE (Professor of Medicine and Surgery, Co-Director Gastrointestinal Oncology) (Professor of Medicine and Surgery, Co-Director Gastrointestinal Oncology)

Rights and permissions

Reprints and permissions

Copyright information

© 2006 Humana Press, Totowa, NJ

About this chapter

Cite this chapter

Naugler, W.E., Hunt, G.C. (2006). Carcinoid Tumors. In: Faigel, D.O., Kochman, M.L. (eds) Endoscopic Oncology. Humana Press. https://doi.org/10.1007/978-1-59745-172-7_15

Download citation

  • DOI: https://doi.org/10.1007/978-1-59745-172-7_15

  • Publisher Name: Humana Press

  • Print ISBN: 978-1-58829-532-3

  • Online ISBN: 978-1-59745-172-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation